Laparoscopic Rectovaginopexy for Neorectal Prolapse After Transanal Total Mesorectal Excision
Joël Shapiro(The Netherlands Cancer Institute), Eelco J. R. de Graaf(Rotterdam University of Applied Sciences), Maarten Vermaas(Association of British Orchestras), Pascal G. Doornebosch(IJsselland Ziekenhuis), Joris J.J.C. de Graaf(IJsselland Ziekenhuis)
Cited by 3
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795
Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)
|British journal of surgery|2015|195
Total Pelvic Exenteration for Primary and Recurrent Malignancies
|World Journal of Surgery|2009|193
Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention
|European Journal of Surgical Oncology|2009|178